Business Wire26d
Artera Announces 1st Patient Enrolled in PROSTATE-IQ Trial to Reduce Burden of Hormone Therapy in Men with Prostate Cancer Recurrence After Prostatectomy
SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announced the first patient enrollment in ...
Yahoo Finance1mon
Artera Announces Collaboration with Tempus to Expand Access to Personalized Prostate Cancer Treatment
Tempus will now offer the ArteraAI Prostate Test to cancer centers across the U.S. SAN FRANCISCO, February 12, 2025--(BUSINESS WIRE)--Artera, the developer of multimodal artificial intelligence ...